nobel biocare holding ag-reg
(NOBN:SIX Swiss Ex)
Executive Profile*
Daniela Bosshardt-HengartnerDirector and Member of Audit Committee, Galenica Ltd. |
| Age | Total Calculated Compensation | This person is connected to 19 board members in 3 different organizations across 3 different industries. See Board Relationships |
| 40 | $149,000 |
Background*
Ms. Daniela Bosshardt-Hengartner served as the Chief Financial Officer of Bellevue Asset Management. Ms. Bosshardt-Hengartner works as an independent consultant in the area of financial analysis and business development for asset managers and companies. She was a Financial Analyst at the Bank am Bellevue from 1998 to 2002 and M2 Capital from 2003 to 2004. She served as management consultant in the Pharma, Medicinal Technology and Biotechnology sectors since 2004. She ...
Corporate Headquarters*Balz Zimmermann-Strasse 7Kloten, Zurich 8302 Switzerland Phone: 41 43 211 53 20 Fax: 41 43 211 32 60 Board Members Memberships*Director 2008-Present Director and Member of Audit Committee 2010-Present Non-Executive Director, Member of Nomination & Compensation Committee and Member of Innovation & Technology Committee
Education*MS Eidgenössische Technische Hochschule Zürich
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*
|
| Recently Viewed | |||
| NOBN:VX | SFr.0.00 CHF | 0.00 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Gregory D. Wasson | Chief Executive Officer, President and Director Walgreen Co. | $1.3M |
| George S. Barrett | Chairman, Chief Executive Officer and Chairman of Executive Committee Cardinal Health, Inc. | $1.3M |
| John H. Hammergren | Chairman, Chief Executive Officer and President McKesson Corporation | $1.7M |
| Markus Pinger | Chairman of the Management Board and Chief Executive Officer Celesio AG | €1.7M |
| Liam M. Fitzgerald | Chief Executive Officer, Director and Member of Nomination Committee United Drug plc | €980.0K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Thornton, CO | IntuitPosted: Apr 29
Sponsored Financial Commentaries
Sponsored Links
To contact NOBEL BIOCARE HOLDING AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
